Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Novel PD-L1 Blocking Peptide with Mitochondrial Targeting Sequence: A Strategy to Counteract Resistance in T-Cell Immunotherapy for Myeloma

Smriti Gurung, Colin Crean, David Lloyd Halladay, Judith L. Anderson, Rafat Abonour, Brian A. Walker, Kelvin P. Lee, John Mitchell Chirgwin, Attaya Suvannasankha

Blood (2024) 144 (Supplement 1): 6861.

https://doi.org/10.1182/blood-2024-211787

Published: 2024

Journal Articles

GFI1-Dependent SGPP1 Repression Promotes Growth and Survival of Myeloma Cells

Daniela Nicoleta Petrusca, PhD, Evgeny Berdyshev, PhD, Colin D. Crean, BS, Judith L Anderson, BS, G. David Roodman, MD PhD

Blood (2019) 134 (Supplement_1): 4387.

https://doi.org/10.1182/blood-2019-131106

Published: 2019

Journal Articles

Targeting the p62-ZZ/N-End Rule Pathway in Multiple Myeloma Overcomes Proteasome Inhibitor-Resistance Via Induction of Necroptosis and Enhances the Bone Anabolic Effects of Proteasome Inhibitors

Silvia Marino, PhD, Daniela Nicoleta Petrusca, PhD, Edward Simpson, PhD, Judith L Anderson, BS, Xiang-Qun Xie, PhDMD,MBA, Yunlong Liu, PhD, John Chirgwin, PhD, G. David Roodman, MD PhD

Blood (2019) 134 (Supplement_1): 4391.

https://doi.org/10.1182/blood-2019-131865

Published: 2019

Journal Articles

The Gfi1-SphK1 Axis Regulates the Growth and Survival of Myeloma Cells

Daniela Nicoleta Petrusca, PhD, Evgeny Berdyshev, PhD, Patrick Mulcrone, PhD, Colin D. Crean, BS, Judith L Anderson, BS, Quanhong Sun, PhD, Deborah Lynn Galson, PhD, G. David Roodman, MD PhD

Blood (2018) 132 (Supplement 1): 5615.

https://doi.org/10.1182/blood-2018-99-119507

Published: 2018

Journal Articles

Inhibition of p62-ZZ Domain-Mediated Signaling Overcomes Bortezomib Resistance in Multiple Myeloma Cells Independent of Their p53 Status

Silvia Marino, PhD, Daniela Nicoleta Petrusca, PhD, Rebecca Silberman, MD, Denise Toscani, PhD, Judith L Anderson, Nicola Giuliani, MD PhD, Xiang-Qun Xie, PhD, Noriyoshi Kurihara, DDS, PhD, G David Roodman, MD PhD

Blood (2017) 130 (Supplement 1): 4421.

https://doi.org/10.1182/blood.V130.Suppl_1.4421.4421

Published: 2017

Journal Articles

Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency

Blood (2016) 128 (17): 2135–2143.

https://doi.org/10.1182/blood-2016-03-706028

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

Second Allogeneic Transplant with Cord Blood for Treatment of Failed First Allogeneic Transplant Due to Primary Graft Failure or Disease Recurrence

Rachel B. Salit, MD, Filippo Milano, MD PhD, Ivy B. Riffkin, David C. Oliver, Nancy L. Anderson, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 3940.

https://doi.org/10.1182/blood.V124.21.3940.3940

Published: 2014

Journal Articles

FLT Imaging Reveals Kinetics and Biology of Engraftment after Myeloablative HSCT

Blood (2014) 124 (21): 1147.

https://doi.org/10.1182/blood.V124.21.1147.1147

Published: 2014

Journal Articles

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

Güllü Topal Görgün, Gregory Whitehill, Jennifer L. Anderson, Teru Hideshima, Craig Maguire, Jacob Laubach, Noopur Raje, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson

Blood (2013) 121 (15): 2975–2987.

https://doi.org/10.1182/blood-2012-08-448548

Published: 2013

Includes: Supplemental data

Journal Articles

The Incidence of Neonatal Abstinence Syndrome in Babies Born to Women with Sickle Cell Disease: A Single Center Study

Cynthia L Anderson, MD, Karin J Blakemore, MD, Sophie Lanzkron, MD, MHS

Blood (2012) 120 (21): 3225.

https://doi.org/10.1182/blood.V120.21.3225.3225

Published: 2012

Journal Articles

Phase II Study of the c-Met Inhibitor ARQ 197 (Tivantinib) in Patients with Relapsed Multiple Myeloma.

Stephan Joseph Dorkhom, D.O., Shadia Zaman, Ph.D., Sheeba K. Thomas, MD, Raymond Alexanian, M.D., Jatin J. Shah, M.D., Donna M. Weber, M.D., Michael Wang, M.D., Martha L. Anderson, R.N., Veerabhadran Baladandayuthapani, Ph.D., Yan Heather Lin, Ph.D., Min Fu, Ph.D., Christine M. Stellrecht, Ph.D., Claudia Morales de Partovi, B.S., Varsha V. Gandhi, Ph.D., Robert Z. Orlowski, M.D., Ph.D.

Blood (2012) 120 (21): 2976.

https://doi.org/10.1182/blood.V120.21.2976.2976

Published: 2012

Journal Articles

Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease

Sonia D'Souza, Davide del Prete, Shunqian Jin, Quanhong Sun, Alissa J. Huston, Flavia Esteve Kostov, Benedicte Sammut, Chang-Sook Hong, Judith L. Anderson, Kenneth D. Patrene, Shibing Yu, Chinavenmeni S. Velu, Guozhi Xiao, H. Leighton Grimes, G. David Roodman, Deborah L. Galson

Blood (2011) 118 (26): 6871–6880.

https://doi.org/10.1182/blood-2011-04-346775

Published: 2011

Includes: Supplemental data

Journal Articles

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

Carlos A. Ramos, MD, Neeharika Narala, MSc, Ann M. Leen, PhD, Ulrike Gerdemann, MD, Matthew L. Anderson, MD, PhD, Erich M. Sturgis, MD, MPH, Barbara Savoldo, MD, PhD, Helen E. Heslop, MD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD

Blood (2011) 118 (21): 1913.

https://doi.org/10.1182/blood.V118.21.1913.1913

Published: 2011

Journal Articles

Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia

Blood (2010) 115 (8): 1519–1529.

https://doi.org/10.1182/blood-2009-03-208629

Published: 2010

Journal Articles

Osteoclasts are important for bone angiogenesis

Frank C. Cackowski, Judith L. Anderson, Kenneth D. Patrene, Rushir J. Choksi, Steven D. Shapiro, Jolene J. Windle, Harry C. Blair, G. David Roodman

Blood (2010) 115 (1): 140–149.

https://doi.org/10.1182/blood-2009-08-237628

Published: 2010

Journal Articles

Factor XIII Val34Leu Polymorphism and the Risk of Myocardial Infarction: A Meta-Analysis.

Mona Shafey, BSc, MD, Josdalyne L. Anderson, B.Sc, Dimitrios Scarvelis, MD, Steve P. Doucette, B.Sc, France Gagnon, PhD, Philip S. Wells, M.Sc., MD

Blood (2005) 106 (11): 1637.

https://doi.org/10.1182/blood.V106.11.1637.1637

Published: 2005

Journal Articles

Factor XIII Val34Leu Polymorphism Is Protective Against Venous Thromboembolism; a Meta-Analysis.

Josdalyne L. Anderson, BSc, Dimitrios Scarvelis, MD, FRCP, Steven Doucette, MSc, Philip S. Wells, MD, FRCP, MSc

Blood (2004) 104 (11): 3512.

https://doi.org/10.1182/blood.V104.11.3512.3512

Published: 2004

Journal Articles

Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU.1

Adrian F. Gombart, Scott H. Kwok, Karen L. Anderson, Yuji Yamaguchi, Bruce E. Torbett, H. Phillip Koeffler

Blood (2003) 101 (8): 3265–3273.

https://doi.org/10.1182/blood-2002-04-1039

Published: 2003

Journal Articles

PU.1 and the Granulocyte- and Macrophage Colony-Stimulating Factor Receptors Play Distinct Roles in Late-Stage Myeloid Cell Differentiation

Karen L. Anderson, Kent A. Smith, Hugh Perkin, Gary Hermanson, Carol-Gay Anderson, Douglas J. Jolly, Richard A. Maki, Bruce E. Torbett

Blood (1999) 94 (7): 2310–2318.

https://doi.org/10.1182/blood.V94.7.2310.419k34_2310_2318

Published: 1999

Journal Articles

Neutrophils Deficient in PU.1 Do Not Terminally Differentiate or Become Functionally Competent

Karen L. Anderson, Kent A. Smith, Frederic Pio, Bruce E. Torbett, Richard A. Maki

Blood (1998) 92 (5): 1576–1585.

https://doi.org/10.1182/blood.V92.5.1576

Published: 1998

NARROW

Novel PD-L1 Blocking Peptide with Mitochondrial Targeting Sequence: A Strategy to Counteract Resistance in T-Cell Immunotherapy for Myeloma

GFI1-Dependent SGPP1 Repression Promotes Growth and Survival of Myeloma Cells

Targeting the p62-ZZ/N-End Rule Pathway in Multiple Myeloma Overcomes Proteasome Inhibitor-Resistance Via Induction of Necroptosis and Enhances the Bone Anabolic Effects of Proteasome Inhibitors

The Gfi1-SphK1 Axis Regulates the Growth and Survival of Myeloma Cells

Inhibition of p62-ZZ Domain-Mediated Signaling Overcomes Bortezomib Resistance in Multiple Myeloma Cells Independent of Their p53 Status

Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency

Second Allogeneic Transplant with Cord Blood for Treatment of Failed First Allogeneic Transplant Due to Primary Graft Failure or Disease Recurrence

FLT Imaging Reveals Kinetics and Biology of Engraftment after Myeloablative HSCT

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

The Incidence of Neonatal Abstinence Syndrome in Babies Born to Women with Sickle Cell Disease: A Single Center Study

Phase II Study of the c-Met Inhibitor ARQ 197 (Tivantinib) in Patients with Relapsed Multiple Myeloma.

Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia

Osteoclasts are important for bone angiogenesis

Factor XIII Val34Leu Polymorphism and the Risk of Myocardial Infarction: A Meta-Analysis.

Factor XIII Val34Leu Polymorphism Is Protective Against Venous Thromboembolism; a Meta-Analysis.

Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU.1

PU.1 and the Granulocyte- and Macrophage Colony-Stimulating Factor Receptors Play Distinct Roles in Late-Stage Myeloid Cell Differentiation

Neutrophils Deficient in PU.1 Do Not Terminally Differentiate or Become Functionally Competent

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only